BMS-986165
CAS: 1609392-27-9
Ref. 3D-JPC39227
| 2mg | 43.00 € | ||
| 5mg | 69.00 € | ||
| 10mg | 106.00 € | ||
| 25mg | 189.00 € | ||
| 50mg | 298.00 € |
Product Information
BMS-986165 is a P-glycoprotein (P-gp) inhibitor that has been shown to reduce the absorption of ciclosporin, tacrolimus, and everolimus in vitro. BMS-986165 has an activity index of 100% and inhibits the inflammatory response by inhibiting the production of cytokines. It has been found to be effective for treating bowel diseases, such as ulcerative colitis and Crohn's disease. The drug also may be used for the treatment of autoimmune diseases, such as psoriasis or rheumatoid arthritis. BMS-986165 is administered orally and is rapidly absorbed. It is metabolized by CYP3A4 and excreted in urine as metabolites. END>>END>>
Chemical properties
Technical inquiry about: 3D-JPC39227 BMS-986165
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
